No abstract

ÖZPeriton diyalizi hastalarında peritonit sık ve önemli bir komplikasyondur. Birçok mikroorganizma özellikle gram pozitif etkenler peritonit etkeni olarak saptanmakla birlikte, zaman zaman nadir izole edilebilen ajanlar da peritonit etkeni olabilmektedir. Achromobacter nadir rastlanan bir enfeksiyon etkenidir ve literatürde birkaç olguda peritonit etkeni olarak görülmüştür, genellikle kateterin çekilmesine neden olmaktadır.Bu yazıda, Achromobacter spp'e bağlı peritonit gelişen bir hastada tedaviye rağmen kontrol edilemeyen enfeksiyon nedeniyle periton kateterinin çekildiği bir hasta sunulmaktadır. ANAHTAR SÖZCÜKLER: Achromobacter, Periton diyalizi, Peritonit ABSTRACTPeritonitis is a common and serious complication of peritoneal dialysis. Many microorganisms and especially gram-positive microorganisms have been determined as a cause of peritonitis. Achromobacter is a rare source of infection and has been isolated as the causing agent of peritonitis in a few cases that resulted in removal of the peritoneal catheter.We herein report a case of Achromobacter peritonitis that resulted in removal of the catheter despite appropriate antibiotic therapy.

Hughes-Stovin Syndrome (HSS) is a rare clinical condition characterized by thrombophlebitis as well as multiple pulmonary and bronchial aneurysms. It commonly presents with coughing, dyspnea, fever, chest pain, and hemoptysis, and its management usually consists of surgical and medical approaches. In this report, we discuss a case of a patient with HSS. A 30-year-old male patient was admitted to the pulmonary medicine ward for hemoptysis. After evaluation with chest CT, bilateral pulmonary embolism and pulmonary aneurysms were observed. Due to a history of aphthous lesions, Behçet's disease (BD) was considered the initial diagnosis; however, the patient did not fit the criteria and was later diagnosed with HSS. Intravenous methylprednisolone was initiated, along with a maintenance treatment with cyclophosphamide. Treatment response was observed in the fourth month; however, due to the persistence of hemoptysis, additional cycles of cyclophosphamide were later required, under which the patient's condition has been stable. HSS currently lacks clear diagnostic criteria, and further studies are needed to investigate genetic backgrounds, familial transmissions, and treatment alternatives.